| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.35B | +0.8% |
| Cost of Revenue | $458.3M | +4.2% |
| Gross Profit | $888.0M | -0.9% |
| R&D Expense | $3.1M | -31.4% |
| SG&A Expense | $709.7M | +18.0% |
| Operating Income | $128.0M | -47.1% |
| Pre-tax Income | $149.8M | -40.1% |
| Income Tax | $43.1M | -42.7% |
| Net Income | $106.7M | -39.0% |
| EPS (Basic) | $1.05 | -28.6% |
| EPS (Diluted) | $1.04 | -28.8% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $125.1M | +39.4% |
| Accounts Receivable | $126.7M | +9.9% |
| Inventory | $79.8M | +3.7% |
| Current Assets | $748.0M | +16.6% |
| Total Assets | $3.40B | +0.9% |
| Current Liabilities | $746.6M | -8.4% |
| Long-term Debt | $102.5M | -75.5% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $296.6M | -33.3% |
| Capital Expenditures | $81.2M | -1.4% |
| Investing Cash Flow | -$68.5M | +75.0% |
| Financing Cash Flow | -$192.7M | -15.2% |
| Free Cash Flow | $215.4M | -40.5% |
| Total Liabilities |
| $1.44B |
| +38.8% |
| Stockholders' Equity | $1.96B | -15.9% |